{"id":"https://openalex.org/W200094186","doi":null,"title":"Drug interactions: concerns and current approaches.","display_name":"Drug interactions: concerns and current approaches.","alternate_titles":[],"publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W200094186","mag":"200094186","pmid":"https://pubmed.ncbi.nlm.nih.gov/17187315"},"language":"en","primary_location":{"id":"pmid:17187315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17187315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W200094186"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015797798","display_name":"Alaa-Eldin F. Nassar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867599234","display_name":"Vion Pharmaceuticals (United States)","ror":"https://ror.org/036dfq243","country_code":"US","type":"company","lineage":["https://openalex.org/I867599234"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alaa-Eldin F Nassar","raw_affiliation_strings":["Vion Pharmaceuticals Inc, 4 Science Park, New Haven, CT 06511, USA. nassaral@aol.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vion Pharmaceuticals Inc, 4 Science Park, New Haven, CT 06511, USA. nassaral@aol.com","institution_ids":["https://openalex.org/I867599234"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111645639","display_name":"Rasmy E. Talaat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rasmy E Talaat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111749463","display_name":"Hajime A. Tokuno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hajime Tokuno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0224,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.70014641,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"10","issue":"1","first_page":"47","last_page":"52"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9240000247955322},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9580000042915344},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.8809999823570251},{"id":"https://openalex.org/keywords/drug-safety-assessment","display_name":"drug safety assessment","score":0.3610000014305115},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7882742285728455},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.6566874980926514},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.5827064514160156},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5134895443916321},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5020186901092529},{"id":"https://openalex.org/C2777494893","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Approved drug","level":3,"score":0.48192524909973145},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4181874990463257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36529815196990967},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001628","descriptor_name":"Beverages","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004790","descriptor_name":"Enzyme Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:17187315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17187315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"IDrugs : the investigational drugs journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1500229808","https://openalex.org/W69827073","https://openalex.org/W1981924471","https://openalex.org/W2476851718","https://openalex.org/W4415404132","https://openalex.org/W4248561961","https://openalex.org/W1982348804","https://openalex.org/W2979054698","https://openalex.org/W7128694963","https://openalex.org/W977715"],"abstract_inverted_index":{"Following":[0],"the":[1,26,31,48,61,71,89,93,99,110,121,146,159,181,187,197],"recent":[2],"withdrawal":[3],"of":[4,14,33,50,59,64,88,113,130,189,199],"several":[5],"prominent":[6],"drugs":[7,90,157],"from":[8,98,158],"US":[9,100],"and":[10,41,53,116,133,176,192],"European":[11],"markets":[12],"because":[13],"detrimental":[15],"drug-drug":[16],"interactions,":[17,191],"metabolic":[18],"drug":[19,34,55,62,72,147,161,190,201,204],"interactions":[20,63],"have":[21,172],"received":[22,37],"considerable":[23],"attention":[24],"in":[25,70,152],"pharmaceutical":[27,182],"industry.":[28,183],"In":[29],"turn,":[30],"question":[32],"safety":[35,112,142,162],"has":[36],"significant":[38],"legal,":[39],"regulatory":[40],"commercial":[42],"emphasis,":[43],"bringing":[44],"this":[45,117],"issue":[46],"to":[47,84,108,140,195],"forefront":[49],"both":[51],"industry":[52],"government":[54],"agendas.":[56],"The":[57,138],"value":[58],"predicting":[60],"compounds":[65],"as":[66,68],"early":[67],"possible":[69],"discovery":[73],"process":[74,149],"for":[75,203],"all":[76],"therapeutic":[77],"areas":[78],"cannot":[79],"be":[80],"underestimated.":[81],"From":[82],"1964":[83],"1999,":[85],"approximately":[86],"8%":[87],"approved":[91,156],"by":[92,120],"FDA":[94],"were":[95],"later":[96],"withdrawn":[97],"market.":[101],"Pharmaceutical":[102],"companies":[103,153],"are":[104,126],"facing":[105],"increasing":[106],"pressure":[107],"prove":[109],"long-term":[111],"their":[114],"products,":[115],"is":[118],"complicated":[119],"fact":[122],"that":[123],"animal":[124],"models":[125],"not":[127,164],"perfectly":[128],"predictive":[129],"human":[131,167],"responses,":[132],"may":[134,150],"provide":[135],"contradictory":[136],"information.":[137],"failure":[139],"address":[141],"concerns":[143],"successfully":[144],"during":[145],"optimization":[148],"result":[151],"withdrawing":[154],"any":[155],"market;":[160],"issues":[163],"only":[165],"present":[166],"health":[168],"consequences,":[169],"but":[170],"also":[171],"a":[173,200],"negative":[174],"economic":[175],"public":[177],"relations":[178],"impact":[179],"on":[180],"This":[184],"paper":[185],"discusses":[186],"significance":[188],"addresses":[193],"strategies":[194],"evaluate":[196],"potential":[198],"candidate":[202],"interactions.":[205]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W200094186","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
